AstraZeneca PLCs LONAZN biologics research and development arm MedImmune has entered into a licensing agreement with Allergan PLC for the global rights to synthetic antibody MEDI2070.MEDI2070 is currently in a Phase IIb clinical trial for moderatetosevere ...
↧